The Norwegian Adult Achondroplasia Study
ClinicalTrials.gov Identifier: NCT03780153
Active study but not recruiting
This study aims to investigate the degree and extent of spinal stenosis, chronic pain, sleep apnoea, impaired hearing, cardiovascular risk factors, and body composition in Norwegian adults with achondroplasia. The study will also explore these factors' impact on physical function, ability to perform daily activities, work participation, and needs for assistive devices and social benefits. The study is conducted in collaboration with the Norwegian Restricted Growth Association, and TRS National Resource Centre for Rare Disorders, Sunnaas Rehabilitation Hospital, Lovisenberg Hospital, and Oslo University Hospital.
| Study Type : | Observational |
| Actual Enrollment : | 50 participants |
| Observational Model: | Cohort |
| Time Perspective: | Cross-Sectional |
| Official Title: | The Norwegian Adult Achondroplasia Study |
| Actual Study Start Date : | March 1, 2017 |
| Actual Primary Completion Date : | March 31, 2019 |
| Estimated Study Completion Date : | January 31, 2022 |
Study Population - Adults 16 years or older with achondroplasia
Inclusion Criteria:
- Residents of Norway
- Aged 16 years or older
- Clinical and genetic diagnosis of achondroplasia
- Speak and understand the Norwegian language.
Exclusion Criteria:
- Severe cognitive deficits, mental illness or substance abuse
- Having a medical condition making them unable to participate in the study.
Investigators
| Study Director: | Vegard Strom, Phd | Sunnaas Rehabilitation Hospital |
